Aspen Pharmacare (APNHY)

Overall impact
B (78)

Commentary

Aspen Pharmacare is a strong overall performer. With a 'B' rating of 78.2 for overall impact (92nd percentile compared to all companies), Aspen Pharmacare ranks 16th out of 154 industry peers, behind Eisai, Astellas Pharma, Daiichi Sankyo and 12 others, and ahead of Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 135 others. On top material causes for Aspen Pharmacare's industry (Pharmaceuticals & Biotech), Aspen Pharmacare performs well in Access to Affordable Healthcare (95.9 score), Accountable Institutions (85.7), Accountable Institutions (91.5) and 6 other causes where it received an 'A' score. Aspen Pharmacare did not receive a 'D' or 'F' rating on any cause.
Impact
Cause APNHY
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
8,867
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
South Africa
Share classes
APNHY
Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Material causes
Ethos considers the following causes material for Aspen Pharmacare, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.